Status:

TERMINATED

Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema

Lead Sponsor:

Greater Houston Retina Research

Conditions:

Diabetic Retinopathy

Diabetic Macular Edema

Eligibility:

All Genders

18+ years

Brief Summary

The DRAGONS study is a non-interventional, prospective study that will 1. characterize disease state biomarker (including cytokines, KKS metabolites, and cell adhesion molecules) levels from aqueous ...

Detailed Description

The DRAGONS study is a non-interventional study investigating aqueous humor biomarker levels in patients with various stages of DR, DME and other retinal pathologies. Subjects will be included in the...

Eligibility Criteria

Inclusion

  • 1\. Subjects with at least one of the following retinal conditions in at least one eye:
  • Treatment naive diabetic retinopathy (group 1 only);
  • Diabetic retinopathy with DME that is incompletely responsive to anti-VEGF therapy at principal investigators discretion with retinal thickening documented on OCT (group 2 only);
  • Various retinal disease including but not limited to diabetic retinopathy without DME which has previously been treated, DME which has responded to anti-VEGF therapy, neovascular age-related macular degeneration, branch or central retinal vein occlusions, epiretinal membrane, or macular hole (group 3 only)

Exclusion

  • Prior intraocular or subtenon steroid injection in the study eye within the prior 1 year of signing informed consent;
  • Prior focal or grid laser photocoagulation in the study eye if within 90 days of signing informed consent;
  • Prior panretinal photocoagulation in the study eye if within 90 days of signing informed consent;
  • Intraocular or refractive surgery in the study eye within 90 days of signing informed consent;
  • Systemic anti-VEGF treatment within 90 days of signing informed consent

Key Trial Info

Start Date :

February 10 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 15 2024

Estimated Enrollment :

107 Patients enrolled

Trial Details

Trial ID

NCT05333055

Start Date

February 10 2022

End Date

May 15 2024

Last Update

January 24 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Retina Consultants of Texas

Bellaire, Texas, United States, 77401

2

Retina Consultants of Texas

Katy, Texas, United States, 77494

3

Retina Consultants of Texas

The Woodlands, Texas, United States, 77384